CClinicalTrials.gg
Sign In
Not yet recruitingNCT07411924Updated Feb 17, 2026

Mastication, Cognition, and Nutritional Status in Multiple Sclerosis

An observational study in Multiple Sclerosis, sponsored by Ondokuz Mayıs University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-17.

Sponsored by Ondokuz Mayıs University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
86
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to investigate the relationship between chewing function and cognitive functions, disease severity, and nutritional status in individuals diagnosed with Multiple Sclerosis

02

Conditions studied

  • Multiple Sclerosis

Browse trials for

03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 660 are open to participants now.

This study's planned enrollment of 86 is below the median of 100 across 1,016 observational studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Ondokuz Mayıs University is the lead sponsor of 263 studies on the registry; 69 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The study population will consist of individuals aged 18 years and older diagnosed with Multiple Sclerosis who are followed up at the neurology outpatient clinics.

Inclusion criteria

  • Being 18 years of age or older

Exclusion criteria

Exclusion Criteria:

  • Having a neurological or systemic disease other than Multiple Sclerosis that may affect chewing function
  • Inability to provide adequate communication or cooperation due to psychiatric disorders
  • Not being diagnosed with Multiple Sclerosis
  • Not volunteering to participate in the study
  • Presence of severe problems preventing questionnaire administration (visual and/or hearing impairments)
  • History or presence of psychiatric and/or other neurological disorders
  • Presence of severe neurological findings that may negatively affect cognitive performance (e.g., severe optic neuritis)
  • Use of medications affecting cognitive functions
  • Alcohol or substance use
  • Having experienced a relapse within the last month
  • Having received corticosteroid treatment within the last month
  • History of stroke, head and neck cancer, or rheumatic diseases that may affect swallowing and chewing performance
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
86 participants (estimated)
Patient registry
No

Groups and cohorts

  • Multiple Sclerosis
06

What researchers measure

Primary outcomes

  1. Expanded Disability Status Scale (EDSS)

    Time frame: Baseline

  2. Montreal Cognitive Assessment (MoCA)

    Time frame: Baseline

  3. Turkish version of the Eating Assessment Scale (T-EAT-10)

    Time frame: Baseline

  4. Dysphagia in Multiple Sclerosis (DYMUS)

    Time frame: Baseline

  5. Test of Masticating and Swallowing Solids (TOMASS)

    Time frame: Baseline

  6. Mini Nutritional Assessment Short Form (MNA)

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07411924
Lead sponsor
Ondokuz Mayıs University
Responsible party
Seda Nur Kemer (Principal investigator, PT, PhD, Ondokuz Mayıs University) — Principal investigator
First posted
Feb 17, 2026
Start date
Mar 1, 2026 (estimated)
Primary completion
Sep 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Feb 17, 2026

Study contacts

Seda Nur Kemer, PhD
Contact
sedakemer@gmail.com
+905467861866

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Multiple Sclerosis→

Other studies from this sponsor

Ondokuz Mayıs University

Start the discussion